Hvivo PLC (LON:HVO) insider Jaime Ellertson purchased 16,401 shares of the stock in a transaction that occurred on Monday, January 8th. The stock was acquired at an average cost of GBX 55 ($0.77) per share, with a total value of £9,020.55 ($12,667.53).
Hvivo PLC (LON:HVO) remained flat at $GBX 54.50 ($0.77) during mid-day trading on Friday. Hvivo PLC has a twelve month low of GBX 50 ($0.70) and a twelve month high of GBX 239.75 ($3.37). The company has a market capitalization of $23.14 and a PE ratio of -272.50.
ILLEGAL ACTIVITY WARNING: “Jaime Ellertson Purchases 16,401 Shares of Hvivo PLC (LON:HVO) Stock” was first published by Dispatch Tribunal and is the property of of Dispatch Tribunal. If you are accessing this story on another site, it was copied illegally and republished in violation of US & international trademark & copyright law. The correct version of this story can be read at https://www.dispatchtribunal.com/2018/02/03/insider-buying-hvivo-plc-hvo-insider-acquires-9020-55-in-stock.html.
hVIVO plc, formerly Retroscreen Virology Group plc, is a holding company. The Company is engaged in a life sciences business pioneering a technology platform of human disease models to accelerate drug discovery and development in respiratory and infectious diseases, including flu, respiratory syncytial virus (RSV), asthma and common cold.
Receive News & Ratings for Hvivo Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Hvivo and related companies with MarketBeat.com's FREE daily email newsletter.